New Data on Vaccines, Dexamethasone Results New Data on Vaccines, Dexamethasone Results
These are the coronavirus stories you need to know about today.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - July 20, 2020 Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news
28-Day Mortality in COVID-19 Lower With Dexamethasone
MONDAY, July 20, 2020 -- Dexamethasone lowers 28-day mortality in patients hospitalized with COVID-19 who are receiving invasive mechanical ventilation or oxygenation alone, according to a study published online July 17 in the New England Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 20, 2020 Category: Pharmaceuticals Source Type: news
A Cheap, Common Steroid Called Dexamethasone May Help Patients With Severe COVID-19, Study Says
A paper published Friday in the New England Journal of Medicine suggests a low-cost steroid may be a valuable treatment for severe COVID-19, building upon encouraging preliminary findings from last month.
In June, U.K. researchers reported that dexamethasone—a cheap, widely available steroid that can lower inflammation in the body—appeared to reduce by a third the risk of death among patients with severe COVID-19. U.K. practitioners began using dexamethasone the very same day the results were announced, but some medical experts were more guarded, arguing no conclusions should be made without seeing the trial...
Source: TIME: Health - July 17, 2020 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 Source Type: news
Coronavirus: Hydroxychloroquine trialled over better treatments
About 200 of 1,200 clinical trials looked at anti-malaria drug hydroxychloroquine as a potential treatment for coronavirus, but fewer than 25 studies examined dexamethasone or remdesivir. (Source: the Mail online | Health)
Source: the Mail online | Health - July 6, 2020 Category: Consumer Health News Source Type: news
Forget any false sense of security: we are still at the start of the global pandemic | Jeremy Farrar
Until every country is protected, we are all at risk. Only effective vaccines and treatments will allow us to eradicate coronavirus• Dr Jeremy Farrar is director of the Wellcome TrustSix months on from the first cases of Covid-19 emerging in Wuhan, many of us in Britain will be feeling a mixture of relief and trepidation as England ’slockdown eases. The loosening of restrictions, alongside warmer weather, has brought hope. The UK government is understandably anxious to get society and the economy back on track. This is what we all want, and it ’s what scientists are striving to ensure.Since the virus began to ripple ...
Source: Guardian Unlimited Science - July 2, 2020 Category: Science Authors: Jeremy Farrar Tags: Coronavirus outbreak Medical research Infectious diseases Science World news Source Type: news
What Coronavirus Researchers Can Learn From Economists
Randomized controlled trials remain the gold standard, but natural experiments can help doctors who need answers now. (Source: NYT Health)
Source: NYT Health - June 30, 2020 Category: Consumer Health News Authors: Anupam B. Jena and Christopher M. Worsham Tags: Dexamethasone (Drug) Coronavirus (2019-nCoV) Economics (Theory and Philosophy) Doctors Research Source Type: news
Gilead ’s $2,340 Price for Coronavirus Drug Remdesivir Draws Criticism
The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries.
Gilead Sciences announced the price Monday for remdesivir, and said the price would be $3,120 for patients with private insurance. The amount that patients pay out of pocket depends on insurance, income and other factors.
“We’re in uncharted territory with pricing a new medicine, a novel medicine, in a pandemic,” Gilead’s chief executive, Dan O’Day, tol...
Source: TIME: Science - June 29, 2020 Category: Science Authors: MARILYNN MARCHIONE / AP Tags: Uncategorized COVID-19 News News Desk Source Type: news
Dexamethasone, CEBM
" If the full published data from the RECOVERY trial of dexamethasone in the treatment of hospitalized patients with COVID-19 confirm the results in the preliminary publications, the decision to adopt it in the NHS before publication of the final paper will have been justified. " (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 29, 2020 Category: Consumer Health News Source Type: news
Health Ministry adds steroid dexamethasone in COVID-19 treatment protocol
The updated protocol includes the advice to use dexamethasone as an alternative choice to methylprednisolone for managing moderate to severe cases of COVID-19. The change has been made after considering the latest available evidence and expert consultation, the ministry said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 26, 2020 Category: Pharmaceuticals Source Type: news
US Demand Outstripping Supply of Steroid Treatment for COVID US Demand Outstripping Supply of Steroid Treatment for COVID
Soaring hospital demand for the steroid dexamethasone, which British researchers say significantly reduces mortality among severely ill COVID-19 patients, is outstripping supply of the drug.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - June 26, 2020 Category: Intensive Care Tags: Infectious Diseases News Source Type: news
Coronavirus Social: Mixed Response to Dexamethasone Preprint Coronavirus Social: Mixed Response to Dexamethasone Preprint
Although many users praised the results of the Recovery trial now in preprint, others want more definitive answers.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - June 26, 2020 Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news
Steroid that helps severely ill coronavirus patients may be dangerous for milder cases
A study from the UK found that dexamethasone, a steroid found to help reduce death rates in severely ill coronavirus patients, was not beneficial in those with mild or early stage cases. (Source: the Mail online | Health)
Source: the Mail online | Health - June 25, 2020 Category: Consumer Health News Source Type: news
Breakthrough Drug for Covid-19 May Be Risky for Mild Cases
That study about dexamethasone has arrived with a big asterisk: While it appears to help severely ill patients, it harms others. (Source: NYT Health)
Source: NYT Health - June 25, 2020 Category: Consumer Health News Authors: Roni Caryn Rabin Tags: your-feed-science Coronavirus (2019-nCoV) Dexamethasone (Drug) Clinical Trials Immune System Drugs (Pharmaceuticals) Steroids Oxford University Source Type: news
US hospital orders soar for Covid-19 steroid treatment
Dexamethasone suppliers unable to keep up with demand, filling only 54 per cent of the orders (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - June 25, 2020 Category: Pharmaceuticals Source Type: news
Coronavirus live news: Saudi Arabia closes borders to hajj attendees as global Covid-19 cases pass 9m
Texas ‘wide open for business’;WHO urges dexamethasone steroid boom; South Africa infections top 100,000. Follow the latest updatesSaudi Arabia closes borders to hajj attendeesHalf of US states see spike as officials warn first wave far from overGlobal cases pass 9 millionBarcelona opera reopens with performance for nearly 3,000 potted plantsSee all our coronavirus coverage10.01amBSTPeople inFrance are being urged to go back to their places of work in a new easing of the coronavirus regulations following a “significant improvement in the health situation”.The employment minister, Muriel P énicaud, will announce a ...
Source: Guardian Unlimited Science - June 23, 2020 Category: Science Authors: Nick Ames (now); Helen Sullivan (earlier) Tags: Coronavirus outbreak World news Science Infectious diseases US news Australia news UK news Microbiology Medical research Brazil Source Type: news
